2020 American Transplant Congress
Delayed Graft Function in the Recipients of Simultaneous Liver and Kidney Transplant: A Single-Center Experience
University of Wisconsin, Madison, WI
*Purpose: Increased rates of delayed graft function (DGF) have been reported in the recipients of simultaneous liver and kidney (SLK) transplant. However, the effect of…2020 American Transplant Congress
Donor-Derived Cell-Free DNA for Detection of Cell-Mediated Rejection in Low Risk Kidney Transplant Patients
Intermountain Medical Center, Murray, UT
*Purpose: Donor-derived cell free DNA (dd-cfDNA) is an emerging non-invasive biomarker for kidney allograft rejection. This has not been externally validated in low risk population.…2020 American Transplant Congress
Impact of a Pharmacist Led Outpatient Tacrolimus Monitoring Protocol in Renal Transplant Recipients
Ohio State University Wexner Medical Center, Columbus, OH
*Purpose: The purpose of this study is to compare the time within therapeutic range (TTR) of tacrolimus (TAC) before and after the initiation of a…2020 American Transplant Congress
Belatacept Monthly Therapy: Transplant Recipients’ Experience
*Purpose: While graft and patient outcomes with belatacept have been relatively well documented, the decision to use belatacept for kidney transplant recipients rests in part…2020 American Transplant Congress
Optimal Perioperative Management of Patients Undergoing Living Donor Nephrectomy Reduces Postoperative Length of Stay and Nausea and Vomiting
*Purpose: Renal transplantation with organs from living donors saves thousands of lives every year. In the perioperative period, poorly controlled nausea and pain can prolong…2020 American Transplant Congress
Recipient and Donor Factors Associated with Post-Donation ESRD in Related White Living Kidney Donors
1Research, UNOS, Richmond, VA, 2Chief Medical Officer, UNOS, Richmond, VA
*Purpose: We studied post-donation ESRD in white first-degree related living kidney donors (RLKDs) in the US between 1994 and 2018 (n=45700); this study is the…2020 American Transplant Congress
Comparative Study between ATG and Grafalon as Induction Agent in Renal Transplant Recipient
Kidney and Liver Transplant, Shahid Dharmabhakta National Transplant Center, Kathmandu, Nepal
*Purpose: Renal transplantation (Rtx) remains the most effective treatment for of end-stage renal disease (ESRD). The development of induction therapy has significantly reduced the incidence…2020 American Transplant Congress
Efficacy of Robotic-Assisted Bilateral Nephrectomy from a Single Approach
Surgery, University of Utah, Salt Lake City, UT
*Purpose: Bilateral native nephrectomies have been established as beneficial for ESRD (end-stage renal disease) patients with select indications in pre-transplant settings to avoid related complications.…2020 American Transplant Congress
Risk Stratification in Antibody Incompatible Kidney Transplantation: Can Aggressive Rejection be Avoided?
*Purpose: Our experience in antibody incompatible kidney transplantation, and anecdotal reports, suggest that a specific form of rejection, which we term Early Aggressive Antibody Mediated…2020 American Transplant Congress
Re-Transplantation (Tx) in Pediatric Patients with Failure of Primary Transplant (Tx) Due to Recurrent Focal Segmental Glomerulosclerosis (FSGS). A Pediatric Nephrology Research Consortium (PNRC) Study
*Purpose: FSGS is a leading cause of end stage renal disease (ESRD). Tx in patients with FSGS may lead to graft failure due to recurrence…
- « Previous Page
- 1
- …
- 31
- 32
- 33
- 34
- 35
- …
- 101
- Next Page »